Literature DB >> 23458598

Suppressing commercial speech is not in the best interests of physicians and patients.

George Chressanthis, Pratap Khedkar, Nitin Jain, Prashant Poddar, Michael Seiders.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 23458598      PMCID: PMC8033939          DOI: 10.1111/jch.12043

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   2.885


× No keyword cloud information.
  6 in total

1.  Bias in high-tier medical journals concerning physician-academic relationships with industry.

Authors:  Roman Lesko; Samuel Scott; Thomas P Stossel
Journal:  Nat Biotechnol       Date:  2012-04-10       Impact factor: 54.908

2.  Pharmaceutical marketing research and the prescribing physician.

Authors:  Jeremy A Greene
Journal:  Ann Intern Med       Date:  2007-05-15       Impact factor: 25.391

3.  ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: a report of the American College of Cardiology Foundation Clinical Quality Committee.

Authors:  David R Holmes; Jeffrey A Becker; Christopher B Granger; Marian C Limacher; Robert Lee Page; Cathy Sila
Journal:  J Am Coll Cardiol       Date:  2011-08-16       Impact factor: 24.094

4.  The Role of Information in Medical Markets: An Analysis of Publicly Reported Outcomes in Cardiac Surgery.

Authors:  David M Cutler; Robert S Huckman; Mary Beth Landrum
Journal:  Am Econ Rev       Date:  2004

5.  Should physicians rely on pharmaceutical detailing for their education?

Authors:  Johan M van Schalkwyk; Martin J Turner
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-12-14       Impact factor: 3.738

6.  Can access limits on sales representatives to physicians affect clinical prescription decisions? A study of recent events with diabetes and lipid drugs.

Authors:  George A Chressanthis; Pratap Khedkar; Nitin Jain; Prashant Poddar; Michael G Seiders
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-21       Impact factor: 2.885

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.